Cognitive Behavioural Therapy for Insomnia for Chinese Adults: a RCT
CBTI
1 other identifier
interventional
90
1 country
1
Brief Summary
Background: Insomnia is a common mental problem, where people experienced difficulty falling asleep, problem maintaining asleep and early morning awakening. It is highly prevalent world-wide and in Hong Kong, causing significant suffering and distress. While evidence based intervention exists, e.g. cognitive-behavioural therapy (CBT), there will not enough therapists to meet treatment demand. A more efficient delivery of treatment, e.g. internet based therapy is called for that can delivery treatment more cost efficiently by requiring lesser therapist time. Objective: This study aims at evaluating the effectiveness of CBTi (Gp) on treating Chinese insomniac adults in Hong Kong. There has been criticism that most clinical trials have been conducted with Caucasians in Western countries and little has been done with ethnic minorities, including Asians in these countries, not to mention Asians in Asian countries, e.g., Chinese in Hong Kong. Design: A two-arm parallel-group randomised controlled trial, comparing the treatment and waitlist group Method: A CBTi protocol would be developed. Approximately 60 Chinese adults with insomnia will be recruited in Hong Kong and randomised into one of the two groups (treatment vs. waitlist). The treatment last for 6 weeks, plus a 3-month follow-up period. The primary outcome measure will be Insomnia Severity Index (ISI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2020
CompletedFirst Submitted
Initial submission to the registry
August 14, 2020
CompletedFirst Posted
Study publicly available on registry
December 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedDecember 7, 2020
December 1, 2020
1.2 years
August 14, 2020
December 3, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Insomnia Symptom Inventory (ISI) (Bastien et al, 2001)
A 7-item self-report questionnaire assessing the nature, severity and the impact of insomnia. Insomnia Symptom Inventory is the primary outcome measure. All items are assessed on a 5-point scale (0-4), with its total score ranging between 0 to 28. Higher score representing worse insomnia symptoms.
Change from baseline Insomnia Symptom Inventory at 3 months
Secondary Outcomes (4)
Change in Dysfunctional Beliefs about Sleep Scale (DBAS) (Morin et al, 2007)
Change from baseline Dysfunctional Beliefs about Sleep Scale at 3 months
Change in Patient Health Questionnaire 9 (PHQ-9) (Kroenke & Spitzer, 2002)
Change from baseline Patient Health Questionnaire 9 (PHQ-9) at 3 months
Change in Generalized Anxiety Disorder-7 item (GAD-7) Questionnaire (Spitzer et al, 2006)
Change from baseline Generalized Anxiety Disorder-7 item (GAD-7) Questionnaire at 3 months
Change in Work and Social Adjustment Scale (WSAS) (Mundt et al, 2002)
Change from baseline Work and Social Adjustment Scale at 3 months
Study Arms (2)
Treatment arm
EXPERIMENTALParticipants in the treatment group will show significant improvement on insomnia symptoms after intervention compared to those in the waitlist control group.
Waitlist control
NO INTERVENTIONParticipants in the waitlist control group will show little improvement on insomnia symptoms after the treatment period of the treatment group.
Interventions
Cognitive behavioural therapy for insomnia
Eligibility Criteria
You may qualify if:
- Insomnia
- Chinese aged 18-65 years old
- Chinese reading and writing proficiency of primary school
- Ability to give consent
- Accept randomization
You may not qualify if:
- substance abuse or dependence
- manic or hypomanic episode
- schizophrenia
- personality disorders
- posttraumatic stress disorder (PTSD)
- mental retardation
- organic mental disorder
- Suicidal risk or a suicidal attempt in the past three months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Clinical Psychology, New Territories East Cluster, Hospital Authority
Hong Kong, Hong Kong
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Psychologist
Study Record Dates
First Submitted
August 14, 2020
First Posted
December 4, 2020
Study Start
June 1, 2020
Primary Completion
August 31, 2021
Study Completion
December 31, 2021
Last Updated
December 7, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share